Cargando…
Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma
Purpose: Systemic therapy has often been used for patients with advanced hepatocellular carcinoma (HCC). However, due to drug resistance, the use of cytotoxic chemotherapy in the treatment of patients with advanced HCC has typically demonstrated low response rates. Secretory clusterin (sCLU) is expr...
Autores principales: | Wang, Xin, Zou, Fang, Zhong, Jingtao, Yue, Longtao, Wang, Fuhai, Wei, Honglong, Yang, Guangsheng, Jin, Tao, Dong, Xiaofeng, Li, Jie, Xiu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929085/ https://www.ncbi.nlm.nih.gov/pubmed/29721050 http://dx.doi.org/10.7150/jca.23849 |
Ejemplares similares
-
Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells
por: Zhong, Jingtao, et al.
Publicado: (2018) -
Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020) -
Gadd45β and Gadd45γ are critical for regulating autoimmunity
por: Liu, Lin, et al.
Publicado: (2005) -
Double-edged Gadd45
por: Powell, Kendall
Publicado: (2005) -
Gadd45 in stress signaling
por: Liebermann, Dan A, et al.
Publicado: (2008)